The TREAT-NMD Advisory Committee for Therapeutics (TACT) held it’s Autumn meeting in Boston earlier this month. Four therapies for neuromuscular diseases were thoroughly reviewed by our expert panel who will […]
Uncategorised
Last Chance to Register for Celebrating 15 Years with TACT!
Don’t miss your chance to be part of a landmark event! Join us on October 31st at the Hyatt Regency in Boston as we proudly celebrate 15 years of the […]
cTAP Study Indicates Duchenne Muscular Dystrophy Clinical Trial Enrollment Criteria Should Expand Beyond Ambulatory Status
A recent study, conducted by the collaborative Trajectory Analysis Project (cTAP) and its international partners, has established some key criteria that could help drug developers identify groups of patients who […]
Last Chance to Get Your Early Bird Ticket for the Upcoming Symposium: Developing Therapies in Rare Neuromuscular Disease
Are you ready to join a transformative event dedicated to advancing the treatment landscape for rare neuromuscular diseases (NMDs)? Don't miss your chance to secure an Early Bird ticket for [...]
TREAT-NMD Achieves ISO 27001:2022 Accreditation for Information Security Management System
We are thrilled to announce that TREAT-NMD has achieved the prestigious ISO 27001:2022 accreditation for our Information Security Management System (ISMS). This milestone underscores our unwavering dedication to ensuring the secure and safe management of all information and systems entrusted to us.
Celebrating 15 Years of TACT: A Milestone Event in Boston
To celebrate 15 years of successful TACT meetings we are very happy to announce some additional events which will take place at the Autumn meeting. Scheduled for October 31st, we will host our very first symposium by the advisory committee: “Developing Therapies in Rare Neuromuscular Disease,”. This symposium promises a day filled with insightful talks, reflecting on the wealth of knowledge gleaned over the past 15 years of TACT’s operation.
